As of 2025-11-04, the Intrinsic Value of Immunovant Inc (IMVT) is -16.90 USD. This IMVT valuation is based on the model Peter Lynch Fair Value. With the current market price of 24.68 USD, the upside of Immunovant Inc is -168.46%.
Based on its market price of 24.68 USD and our intrinsic valuation, Immunovant Inc (IMVT) is overvalued by 168.46%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -16.90 - -16.90 | -16.90 | -168.46% |
| P/E | (81.44) - (82.12) | (87.78) | -455.7% |
| DDM - Stable | (19.06) - (47.47) | (33.27) | -234.8% |
| DDM - Multi | (2.66) - (5.26) | (3.54) | -114.4% |
| Market Cap (mil) | 3,266.70 |
| Beta | 1.23 |
| Outstanding shares (mil) | 132.36 |
| Enterprise Value (mil) | 2,667.79 |
| Market risk premium | 4.60% |
| Cost of Equity | 13.41% |
| Cost of Debt | 5.00% |
| WACC | 9.20% |